What Does the Kidney Do?
Anyone travelling on a long highway after 3 cups of coffee becomes really aware of their kidneys very quickly. But, besides getting rid of excess water, the kidney has other… Read more
An Inside Look at Risk Based Monitoring
Risk Based Monitoring (RBM) is a clinical trial-monitoring method that was developed to fulfil regulatory requirements but moves away from 100% source data verification (SDV) of patient data. RBM, in… Read more
Behind the Scenes of Clinical Research
Clinical research provides doctors important information on how to effectively treat patients, and is what makes the development of new medicines, new procedures and new tools possible. Clinical research allows… Read more
Patient Interaction in Renal Research – Leading with a Servant’s Heart
It’s 5:30 in the morning and I’m walking into a dialysis center in the suburbs of the Twin Cities. Who would have thought this is what I would be doing… Read more
SMO, and Other Dirty Words: A Guide to Different Models of SMOs
Like many other site organizations, DaVita Clinical Research has struggled with defining ourselves within an industry that holds firm to their acronyms. CRO, or contract research organization, has been able… Read more
Interpreting the Guideline for Good Clinical Practice
The Guideline for Good Clinical Practice (GCP) is a set of guidelines written by the International Council for Harmonization of Technical Requirements for Pharmaceuticals for Human Use (ICH). These guidelines… Read more
DCR BioReG Update
The DaVita Clinical Research (DCR) Biorepository Grant Program (BioReG) was formed support precision-based medicine innovation in nephrology. To see an update of the BioReG Gran Program, please click the… Read more
Nephrology Research: How Will We Find a Cure?
Chances are that you or someone you know has faced a cancer diagnosis. It’s also likely that after a diagnosis, the possibility of participating in clinical trials was highlighted. For… Read more
Enrolling Dialysis Patients for Clinical Trials
Patient enrollment for clinical trials can be a challenging task especially if the patients are dealing with a chronic illness. Dialysis patients in particular are a population that need a… Read more
How Biosimilars Could Impact Clinical Trials
Over the next few years, the patents for many therapeutic biologics will expire, allowing drug manufacturers to request US Food and Drug Administration (FDA) approval for biosimilars, medical products which… Read more